Blepharitis other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 38: Line 38:
===Biopsy===
===Biopsy===
Biopsy of the eyelid may be indicated in the following conditions:
Biopsy of the eyelid may be indicated in the following conditions:
*Blepharitis with marked [[asymmetry]] (possibility of [[carcinoma]])
*Blepharitis with marked asymmetry (possibility of [[carcinoma]])
*Blepharitis not responding to therapy
*Blepharitis not responding to therapy
*Unifocal recurrent blepharitis with [[chalazion|chalazia]]
*Unifocal recurrent blepharitis with [[chalazion|chalazia]]

Revision as of 19:37, 27 July 2016

Blepharitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Blepharitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Blepharitis other diagnostic studies On the Web

recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Blepharitis other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Blepharitis other diagnostic studies

CDC on Blepharitis other diagnostic studies

Blepharitis other diagnostic studies in the news

Blogs on Blepharitis other diagnostic studies

Directions to Hospitals Treating Blepharitis

Risk calculators and risk factors for Blepharitis other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Other diagnostic studies for blepharitis include slit lamp examination, tear break up time (TBUT), and measurement of tear osmolarity.[1][2][3]

Other Diagnostic Studies

Other diagnostic studies for blepharitis include:[1][2][3][4]

Slit lamp examination

On slit lamp examination, blepharitis is characterized by:

Images

The following are slit lamp examination images associated with blepharitis:[1]

Tear Break Up Time

On tear break up time (TBUT), blepharitis is characterized by tear film instability and rapid evaporation.

Measurement of Tear Osmolarity

On measurement of tear osmolarity, blepharitis concurrent with dry eye syndrome may be characterized by tear osmolarity of 316 mOsm/L or greater.

Microscopic evaluation of eyelashes

On microscopic evaluation of eyelashes, chronic blepharoconjunctivitis may be characterized by the presence of Demodex mites.

Biopsy

Biopsy of the eyelid may be indicated in the following conditions:

  • Blepharitis with marked asymmetry (possibility of carcinoma)
  • Blepharitis not responding to therapy
  • Unifocal recurrent blepharitis with chalazia

References

  1. 1.0 1.1 1.2 Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI; et al. (2011). "The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee". Invest Ophthalmol Vis Sci. 52 (4): 2006–49. doi:10.1167/iovs.10-6997f. PMC 3072162. PMID 21450918.
  2. 2.0 2.1 Driver PJ, Lemp MA (1996). "Meibomian gland dysfunction". Surv Ophthalmol. 40 (5): 343–67. PMID 8779082.
  3. 3.0 3.1 Bachmeyer C, Bégon E (2013). "Chronic blepharitis". Neth J Med. 71 (5): 259–63. PMID 23799315.
  4. McCulley JP, Dougherty JM (1985). "Blepharitis associated with acne rosacea and seborrheic dermatitis". Int Ophthalmol Clin. 25 (1): 159–72. PMID 3156100.

Template:WH Template:WS